ClinicalTrials.gov record
Completed Phase 2 Interventional

Vinorelbine in Treating Children With Recurrent or Refractory Cancers

ClinicalTrials.gov ID: NCT00003234

Public ClinicalTrials.gov record NCT00003234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 10:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Navelbine (Vinorelbine) In Children With Recurrent Or Refractory Malignancies

Study identification

NCT ID
NCT00003234
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Children's Oncology Group
Network
Enrollment
50 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
Up to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 1998
Primary completion
Feb 28, 2006
Completion
Feb 28, 2007
Last update posted
Jul 27, 2014

1998 – 2007

United States locations

U.S. sites
10
U.S. states
4
U.S. cities
10
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300
University of South Alabama Medical Center Mobile Alabama 36617-2293
Phoenix Children's Hospital Phoenix Arizona 85006
Arizona Cancer Center Tucson Arizona 85724
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
Southern California Permanente Medical Group Downey California 90242
Cancer Center and Beckman Research Institute, City of Hope Duarte California 91010-3000
University of California San Diego Cancer Center La Jolla California 92093-0658
Loma Linda University Medical Center Loma Linda California 92354
Jonathan Jaques Children's Cancer Center Long Beach California 90801-1428

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 27, 2014 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003234 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →